glp-1 receptor agonists for type 2 diabetes Could Help Prevent Infections in People with Diabetes? A Nationwide Study Says Yes—At Least the Lungs and Feet #ActAgainstAmputation #DiabeticFoot #GLP1RA GLP-1 Receptor Agonists and SGLT2

Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants

Endotoxin testing confirms bacterial contamination remains below safety thresholds

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor An Update

FDA procedurally removed it from Category 2 in April 2026 after nominators withdrew their submissions and referred it to the Pharmacy Compounding Advisory Committee, which is scheduled to review it on July 23-24, 2026 for possible inclusion on the approved 503A bulks list

Mass spectrometry complements liquid chromatography by providing exact molecular weight verification